Domestic manufacturing sectors within ASEAN member states, while increasingly diversified, are largely focused on the assembly of products designed and manufactured elsewhere. There is also too much reliance on the export of natural resources.
Trade and Intellectual Property
In recent years cyber attacks in the world have left losses close to 12,000 million dollars, through the BEC modality or commitment of business accounts according to the FBI. In Colombia attacks grew 612% in 2018 and there are fears that trends in cyber crime suggest that increasing targets are AI firms and private data and property.
Italy's recent joining of China's Belt and Road Initiative has raised many questions, the one focused on in this report being how the variations in IP systems between the involved countries exposes investors to additional risks.
Improving access to quality healthcare remains a key area of action for the member states of the United Nations. As they gather in New York for the 74th UN General Assembly, focus is upon the health-related Sustainable Development Goals. This paper adds to this debate by providing international trade policy suggests that would enhance universal healthcare by reducing unnecessary medicine costs and accelerating access to medicine.
This study develops a quantitative analysis of the impact of the Canada-United States-Mexico Agreement (CUSMA), as signed on 30 November 2018. The CUSMA represents a major overhaul of the now-dated 1994 North American Free Trade Agreement (NAFTA) and is based largely on the Trans-Pacific Partnership (TPP) text, signed in 2016, from which the Trump administration withdrew in January 2017.
The Philippine Institute for Development Studies (PIDS) has released its annual report for 2018 detailing its accomplishments in research, policy recommendation, and collaboration in numerous fields effecting economic outcomes.
As parties to the United States-Mexico-Canada Agreement (USMCA), Canada and Mexico have agreed to adopt important intellectual property protections for biologic medicines.
In a world where economic growth increasingly depends on “intangible” products and services based on human know-how, knowledge and creativity, only those countries that have the right policy attitude to innovation will thrive.
Robust intellectual property (IP) protection is vital for biopharmaceutical innovation. It provides the incentives and business certainty needed to attract and sustain long-term investment in prevention, treatments and cures. IP rights have little value without enforcement, however.
Canadian courts, in particular the Supreme Court of Canada, have in recent years issued intellectual property (IP) judgments that were problematic, even erroneous, Munk Senior Fellow Richard Owens said today.